Cargando…
β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study
AIMS: The effect of first-line antianginal agents, β-blockers, and calcium antagonists on clinical outcomes in stable coronary artery disease (CAD) remains uncertain. METHODS AND RESULTS: We analysed the use of β-blockers or calcium antagonists (baseline and annually) and outcomes in 22 006 stable C...
Autores principales: | Sorbets, Emmanuel, Steg, Philippe Gabriel, Young, Robin, Danchin, Nicolas, Greenlaw, Nicola, Ford, Ian, Tendera, Michal, Ferrari, Roberto, Merkely, Bela, Parkhomenko, Alexander, Reid, Christopher, Tardif, Jean-Claude, Fox, Kim M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503455/ https://www.ncbi.nlm.nih.gov/pubmed/30590529 http://dx.doi.org/10.1093/eurheartj/ehy811 |
Ejemplares similares
-
Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2018) -
Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry
por: Sorbets, Emmanuel, et al.
Publicado: (2020) -
Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease
por: Sorbets, Emmanuel, et al.
Publicado: (2017) -
Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease
por: Steg, Ph. Gabriel, et al.
Publicado: (2012) -
Simple risk models to predict cardiovascular death in patients with stable coronary artery disease
por: Ford, Ian, et al.
Publicado: (2020)